Jonathan Milner Overview

  • Investor Type
  • Angel

  • Status
  • Active

  • Professionals
  • 1

Professionals
  • Investments
  • 61

  • Portfolio
  • 37

  • Exits
  • 7

Exits

Jonathan Milner General Information

Description

Dr. Jonathan Milner is a Co-Founder and serves as Chairman at Axol Biosciences. He serves as Board Member at GeoSpock. He also serves as a Member of the Advisory Panel at Cambridge Innovation Capital. he is a co-founder and currently Deputy Chairman of Abcam plc, is an experienced entrepreneur and investor and is passionate about supporting UK healthcare and high-tech start-ups. He has provided considerable investment and support to over 40 companies and has assisted three technology companies to IPO on AIM. Jonathan gained his doctorate in Molecular Genetics at Leicester University after graduating in Applied Biology at Bath University. From 1992-95, he was a post-doctoral researcher at Bath, following which he worked at the University of Cambridge in the laboratory of Professor Tony Kouzarides researching the molecular basis of breast cancer. He identified the market opportunity for supplying high-quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Kouzarides. Jonathan is currently Chairman of Axol Bioscience, Camallergy Limited, Definigen Limited, and PhoreMost Limited and a non-executive director of Horizon Discovery, Syndicate Room Limited, Repositive Limited, Elpis Biomedical Limited, Shift Biosciencs Limited, and HealX Limited. He also sits on the advisory board of Desktop Genetics Ltd.

Contact Information

Investor Status
Actively Seeking New Investments
Primary Investor Type
Angel (individual)
Primary Office
  • Cambridge
  • England, United Kingdom

Jonathan Milner Investments (61)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Nuclera 06-Jul-2022 Later Stage VC 000.00 Biotechnology Generating Revenue 00000000 000000 00.0
000000 14-Jun-2022 00000 00000 00.000 Drug Discovery Generating Revenue 00000000 000000 00.0
000000 00000000000 20-May-2022 00000 00000 000.00 Drug Discovery Startup 00000000 000000 00.0
0000 0000000000 07-Apr-2022 00000 00000 00.00 Biotechnology Generating Revenue 00000000 000000 00.0
0000 00000000000 17-Jan-2022 0000 00000 00.000 Drug Discovery Pre-Clinical Trials 00000000 000000 00.0
00000 000000000000 17-Nov-2021 00000 00000 000.00 Diagnostic Equipment Generating Revenue 00000000 000000 00.0
0000000 000000000 19-Oct-2021 0000 00000 00.00 Discovery Tools (Healthcare) Generating Revenue 00000000 000000 00.0
000000000 07-Oct-2021 00000 00000 00.000 Drug Discovery Generating Revenue
Bactobio 26-Aug-2021 Early Stage VC 00.000 Biotechnology Startup 00000000 000000 00.0
NanoSyrinx 13-Jul-2021 Seed Round 00.000 Drug Delivery Generating Revenue 00000000 000000 00.0
You’re viewing 10 of 61 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Jonathan Milner Exits (7)

Company Name Exit Date Exit Type Exit Size
Sense Biodetection 02-Feb-2023 Merger/Acquisition
0000000 01-Nov-2022 0000000000: 000000
0000000000 12-Nov-2021 0000000000: 000000
0000000 00000000 01-Jun-2018 000000000000000000
00000000000 21-Jun-2017 000 00 00000000
Oval Medical Technologies 13-Dec-2016 Merger/Acquisition
Horizon Discovery 27-Mar-2014 IPO 00000
To view Jonathan Milner’s complete exits history, request access »

Jonathan Milner Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Jonathan Milner Team (1)

Name Title Deals Funds Boards Office
Jonathan Milner Ph.D Angel Investor 00 0 Cambridge, United Kingdom
To view Jonathan Milner’s complete team members history, request access »

Jonathan Milner Co-Investors (108)

Name With Exits Lead Partner Series Industry
Parkwalk Advisors 6 0 Series chart Industry bar
O2h Ventures 0 0 Series chart Industry bar
Start Codon 0 0 Series chart Industry bar
SyndicateRoom 0 0 Series chart Industry bar
UK Innovation & Science Seed Fund 0 0 Series chart Industry bar
You’re viewing 5 of 108 co-investors. Get the full list »